专利信息

首页上页 1 2 3 4 5 6 7 8 9 10 下页尾页共 2262 条记录, 当前第5/227页。

专利标题：Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression

专利权人：Universitat Basel;

The invention relates to a combination of syrosingopine and a mitochondrial inhibitor e.g. metformin or oligomycin and the use of the combination of syrosingopine and a mitochondrial inhibitor for the treatment of cancer and for achieving immunosuppression. The invention also relates to a fluorescence-based method for predicting syrosingopine sensitivity of a cancer cell.

专利标题：Combination method and preparation process of pioglitazone hydrochloride sustained-release pellet preparation

专利权人：No.150 Central Hospital, Pla;

专利标题：Metformin hydrochloride dry suspension and preparation method thereof

专利标题：Preparation method of sitagliptin metformin hydrochloride compound preparation

专利标题：Tablet formulation comprising repaglinide and metformin

专利权人：Novo Nordisk A/s;

The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.

专利标题：PHARMACEUTICAL COMPOSITIONS COMPRISING (1S)-1,5-ANHYDRO-1-[5-(4-ETHOXYBENZYL)-2-METHOXY-4-METHYLPHENYL]-1-THIO-D-GLUCITOL AND METFORMIN AND USES THEREOF IN THE TREATMENT OF DIABETES

专利权人：TAISHO PHARMA CO LTD [JP];

专利标题：Pharmaceutical preparation comprising metformin and hmg-coa reductase inhibitor

专利权人：Cj Cheiljedang Corporation;

The present invention relates to a pharmaceutical combined formulation comprising metformin and an HMG-CoA reductase inhibitor and a preparation method therefor and more specifically to a pharmaceutical combined formulation and a preparation method therefor the pharmaceutical combined formulation comprising: a first composition comprising a core layer comprising metformin or a pharmaceutically acceptable salt thereof and a water-insoluble polymer and a hydrophobic base coating layer formed on th...

A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and optionally at least one pharmaceutically acceptable excipient wherein the composition comprises methionine as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.

The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer an SGLT2 inhibitor formulation as the second layer and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.

Liquid composition comprises a glucagon-like peptide-1 (GLP-1) agonist and/or its salt an insulin and/or its salt optionally at least one adjuvant and methionine. Independent claims are also included for: (1) a combination comprising a first pharmaceutical composition and a second pharmaceutical composition and optionally at least one additional pharmaceutical composition each having at least one insulin and at least one GLP-1 agonist where at least one insulin and/or at least one GLP-1 agonist ...

当前查询条件: [药品] 包含 'Metformin '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. KR20130142164A	2013/12/27	KR20137016147	2012/1/9
专利标题：Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression 专利权人：Universitat Basel; The invention relates to a combination of syrosingopine and a mitochondrial inhibitor e.g. metformin or oligomycin and the use of the combination of syrosingopine and a mitochondrial inhibitor for the treatment of cancer and for achieving immunosuppression. The invention also relates to a fluorescence-based method for predicting syrosingopine sensitivity of a cancer cell.

2. CN103462903A	2013/12/25	CN20131377195	2013/8/26
专利标题：Combination method and preparation process of pioglitazone hydrochloride sustained-release pellet preparation 专利权人：No.150 Central Hospital, Pla;

3. CN103462900A	2013/12/25	CN20131397501	2013/9/2
专利标题：Metformin hydrochloride dry suspension and preparation method thereof 专利权人：Tianjin Juxing Kanghua Medical Technology Co., Ltd.;

4. CN103463090A	2013/12/25	CN20131412920	2013/9/11
专利标题：Preparation method of sitagliptin metformin hydrochloride compound preparation 专利权人：Shenzhen Hybio Pharmaceutical Co., Ltd.;

5. EP2026787B1	2013/12/25	EP20070728962	2007/5/10
专利标题：Tablet formulation comprising repaglinide and metformin 专利权人：Novo Nordisk A/s; The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.

6. HRP20131120T1	2013/12/20	HR2013P001120T	2013/11/25
专利标题：PHARMACEUTICAL COMPOSITIONS COMPRISING (1S)-1,5-ANHYDRO-1-[5-(4-ETHOXYBENZYL)-2-METHOXY-4-METHYLPHENYL]-1-THIO-D-GLUCITOL AND METFORMIN AND USES THEREOF IN THE TREATMENT OF DIABETES 专利权人：TAISHO PHARMA CO LTD [JP];

7. KR20130139010A	2013/12/20	KR20120062661	2012/6/12
专利标题：Pharmaceutical preparation comprising metformin and hmg-coa reductase inhibitor 专利权人：Cj Cheiljedang Corporation; The present invention relates to a pharmaceutical combined formulation comprising metformin and an HMG-CoA reductase inhibitor and a preparation method therefor and more specifically to a pharmaceutical combined formulation and a preparation method therefor the pharmaceutical combined formulation comprising: a first composition comprising a core layer comprising metformin or a pharmaceutically acceptable salt thereof and a water-insoluble polymer and a hydrophobic base coating layer formed on th...

8. RU2012123739A	2013/12/20	RU20120123739	2010/11/11
专利标题：专利权人： A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and optionally at least one pharmaceutically acceptable excipient wherein the composition comprises methionine as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.

9. RU2012123947A	2013/12/20	RU20120123947	2010/11/12
专利标题：专利权人： The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer an SGLT2 inhibitor formulation as the second layer and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.

10. RU2012124069A	2013/12/20	RU20120124069	2010/11/11
专利标题：专利权人： Liquid composition comprises a glucagon-like peptide-1 (GLP-1) agonist and/or its salt an insulin and/or its salt optionally at least one adjuvant and methionine. Independent claims are also included for: (1) a combination comprising a first pharmaceutical composition and a second pharmaceutical composition and optionally at least one additional pharmaceutical composition each having at least one insulin and at least one GLP-1 agonist where at least one insulin and/or at least one GLP-1 agonist ...

下载范围

下载内容